Skip to content
Recall Observatory FDA recall evidence

Drug product

PHENOBARBITAL Sodium Injection, USP, 65mg/mL, packaged as a) 25 x 1 mL Vials per box (NDC 42494-415-25) and b) 3 x 1 mL Vials per box (NDC 42494-415-03), Rx only, Manufactured for Cameron Pharmaceuticals, LLC.

D-0743-2022

March 14, 2022

Class II

Product summary

Firm
Vitae Enim Vitae Scientific, Inc.
Event
Event 89803
Status
Terminated
Classification
Class II
Quantity
a) 21,501 boxes; b) 4,846 boxes
Official record key
drug-enforcement:D-0743-2022

Official wording

Reason: Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Code information: Lot #: a) 20VPSI007, Exp 3/31/2022; 20VPSI015, Exp 5/30/2022; 20VPSI018, Exp 6/1/2022; 20VPSI032, Exp 11/30/2022; 21VPSI002, 21VPSI003, Exp 1/31/2023; 21VPSI006, Exp 3/31/2023; 21VPSI012, 21VPSI020, Exp 5/31/2023; 21VPSI035, Exp 7/31/2023; 21VPSI037, 21VPSI038, Exp 8/31/2023; 21VPSI043, 21VPSI044, Exp 10/31/2023; 21VPSI050, 21VPSI051, Exp 11/30/2023; 22VPSI004, Exp 7/31/2024; 22VPSI006, Exp 8/31/2024; b) 20VPSI008, Exp 3/31/2022; 20VPSI019, Exp 6/30/2022; 21VPSI050, Exp 11/30/2023,

Distribution pattern: Nationwide in the U.S.A

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    deviations from Current Good Manufacturing Practices
  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility